Prevalence of fosfomycin resistance among ESBL-producing Escherichia coli isolates in the community, Switzerland
Our aim was to evaluate the prevalence of fosfomycin-resistant strains among ESBL-producing Escherichia coli isolates recovered from community patients in Switzerland. A total of 1225 ESBL-producing E. coli isolates were collected between 2012 and 2013 from a private and community laboratory. Fosfomycin resistance was assessed by using the novel rapid fosfomycin/E. coli NP test and agar dilution method. Resistant isolates were further investigated for acquired resistance genes fosA1–7 by PCR and sequencing. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were performed to evaluate the clonal relationship among fosA3-carrying isolates. Out of the 1225 ESBL-producing E. coli isolates analyzed in this study, 1208 were fosfomycin susceptible while 17 were fosfomycin resistant. No discrepancy was observed between the rapid fosfomycin/E. coli NP test and the agar dilution method taken as the gold standard. Five out of the 17 resistant isolates carried a fosA-like gene. No clonal relationship was observed among those isolates. Here, the prevalence of fosfomycin resistance among ESBL-producing E. coli isolates in the community is reported for the first time in Switzerland, being ca. 1.4%. Among the five isolates carrying a fosA gene, four encoded the FosA3 enzyme, being the most prevalent fosfomycin-resistant determinant. An excellent correlation was observed between minimum inhibitory concentration–based susceptibility categorization and results of the rapid fosfomycin/E. coli NP test, further indicating the excellent sensitivity and specificity of this recently developed rapid test whose results are obtained in less than 2 h.
KeywordsRapid test Enterobacterales
This work was funded by the Swiss National Science Foundation (project FNS-407240_177382).
- 12.Wachino J, Yamane K, Suzuki S, Kimura K, Arakawa Y (2010) Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother 54(7):3061–3064CrossRefGoogle Scholar
- 17.Peretz A, Naamneh B, Tkhawkho L, Nitzan O (2019) High rates of fosfomycin resistance in Gram-negative urinary isolates from Israel. Microb Drug Resist In press 0(0):1-5Google Scholar
- 18.Institute CaLS (2018) Performance standards for antimicrobial susceptibility testing; 28th informational supplement. CLSI document M100-S28. Clinical and Laboratory Standards Institute, Wayne, PAGoogle Scholar
- 19.European Committee on Antimicrobial Susceptibility Testing (2019) Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf Accessed 10 jan 2019
- 20.Nordmann P, Poirel L, Mueller L (2019) Rapid detection of Fosfomycin resistance in Escherichia coli. J Clin Microbiol 57(1):e01531–e01518Google Scholar
- 21.Erb S, Frei R, Tschudin Sutter S, Egli A, Dangel M, Bonkat G et al (2018) Basic patient characteristics predict antimicrobial resistance in E. coli from urinary tract specimens: a retrospective cohort analysis of 5246 urine samples. Swiss Med Wkly 148:w14660Google Scholar
- 22.Lee SY, Park YJ, Yu JK, Jung S, Kim Y, Jeong SH et al (2012) Prevalence of acquired fosfomycin resistance among extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother 67(12):2843–2847CrossRefGoogle Scholar